AMGEN INC — Director's Dealing 2020

Dec 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2020-12-15

Reporting Person: AMGEN INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-15	American Depositary Shares	A	67941	$239.3065	Acquired	18592314	Direct
2020-12-16	American Depositary Shares	A	85573	$248.2612	Acquired	18677887	Direct
2020-12-17	American Depositary Shares	A	74624	$260.5396	Acquired	18752511	Direct

Footnotes

F1: This transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.

F2: The price reported is an average price. These American Depositary Shares ("ADSs") were purchased at prices ranging from $232.86 to $241.845 per ADS. Full information regarding the number of ADSs purchased at each separate price is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F3: The price reported is an average price. These ADSs were purchased at prices ranging from $241.29 to $250.17 per ADS. Full information regarding the number of ADSs purchased at each separate price is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F4: The price reported is an average price. These ADSs were purchased at prices ranging from $254.135 to $265.00 per ADS. Full information regarding the number of ADSs purchased at each separate price is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F5: As each ADS represents 13 Ordinary Shares of the Issuer, the reported securities represent 243,782,643 Ordinary Shares.